Dermatitis

Dermatitis is the indication for 25 drugs in DrugBank. It is covered by 35 curated, structured indications.

Also known as: Skin Inflammation
Classified under: Skin and Subcutaneous Tissue Diseases
Indicated drugs: Balsam of Peru
Bendazac
Chloroxine
Chlorquinaldol
Clotrimazole
Dexamethasone
Dexamethasone acetate
Dexchlorpheniramine
Difluocortolone
Econazole
Flumethasone
Fluocortolone
Fluticasone propionate
Hydrocortisone
Linoleic acid
Meclocycline
Metronidazole
Mometasone
Mometasone furoate
Neomycin
Phenol
Pine tar
St. John's Wort
Triamcinolone
Urea

Resolves to

Vocabularies

MeSHM0006046ICD-10L30.9SNOMED CT156326000MedDRA10012431UMLSC0011603

What you can answer from here — as of October 03, 2026

25Indicated drugsWith each drug's targets and mechanism

Listed above

35Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

204Clinical trialsPhase, status and sponsor resolved per trial

4Contraindicated drugsDrugs whose labels contraindicate them in this condition

130Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Dermatitis share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.